Whipple's disease

Internal and Emergency Medicine

Volumn 7, Issue SUPPL. 3, 2012, Pages 209-213

  Biagi, Federico ^a   Trotta, Lucia ^a   Corazza, Gino R ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Immune reconstitution syndrome; Tropheryma whipplei; Whipple's disease

Indexed keywords

ANTIINFECTIVE AGENT; GLUCOCORTICOID;

ARTICLE; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOLOGY; INTESTINE LIPODYSTROPHY; POLYMERASE CHAIN REACTION; RECURRENT DISEASE;

ANTI-BACTERIAL AGENTS; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; POLYMERASE CHAIN REACTION; RECURRENCE; WHIPPLE DISEASE;

EID: 84867719304     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-012-0801-1     Document Type: Article

References (40)

1. Fenollar F, Puéchal X, Raoult D (2007) Whipple's disease. N Engl J Med 356: 55-66.
2. Schneider T, Moos V, Loddenkemper C et al (2008) Whipple's disease: new aspects of pathogenesis and treatment. Lancet Infect Dis 8: 179-190.
3. Moos V, Schneider T (2011) Changing paradigms in Whipple's disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis 30: 1151-1158.
4. Feurle GE, Moos V, Schinnerling K et al (2010) The immune reconstitution inflammatory syndrome in Whipple disease. A cohort study. Ann Intern Med 153: 710-717.
5. Li W, Fennolar F, Rolain J-M et al (2008) Genotyping reveals a wide heterogenity of Tropheryma whipplei. Microbiology 154: 521-527.
6. Maiwald M, Schuhmacher F, Ditton HJ et al (1998) Environmental occurrence of the Whipple's disease bacterium (Tropheryma whippelii). Appl Environ Microbiol 64: 760-762.
7. Schöniger-Hekele M, Petermann D, Weber B et al (2007) Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol 73: 2033-2035.
8. Zinkernagel AS, Gmür R, Fenner L et al (2003) Marginal and subgingival plaque-a natural habitat of Tropheryma whipplei? Infection 31: 86-91.
9. Fenollar F, Trani M, Davoust B et al (2008) Prevalence of asymptomatic Tropheryma whipplei carriage among humans and nonhuman primates. J Infect Dis 197: 880-887.
10. Fenollar F, Mediannikov O, Socolovschi C et al (2010) Tropheryma whipplei bacteremia during fever in rural West Africa. Clin Infect Dis 51: 515-521.
11. Raoult D, Fenollar F, Rolain JM et al (2010) Tropheryma whipplei in children with gastroenteritis. Emerg Infect Dis 16: 776-782.
12. Martinetti M, Biagi F, Badulli C et al (2009) The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple's disease. Gastroenterology 136: 2289-2294.
13. Ponz de Leon M, Borghi A, Ferrara F et al (2006) Whipple's disease in a father-son pair. Intern Emerg Med 1: 254-256.
14. Dykman DD, Cuccherini BA, Fuss IJ et al (1999) Whipple's disease in a father-daughter pair. Dig Dis Sci 44: 2542-2544.
15. Gross JB, Wollaeger EE, Sauer WG et al (1959) Whipple's disease; report of four cases, including two in brothers, with observations on pathologic physiology, diagnosis, and treatment. Gastroenterology 36: 65-93.
16. Moos V, Kunkel D, Marth T et al (2006) Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease. J Immunol 177: 2015-2022.
17. Raoult D, Lepidi H, Harle JR (2001) Tropheryma whipplei circulating in blood monocytes. N Engl J Med 345: 548.
18. Kalt A, Schneider T, Ring S et al (2006) Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease. Int J Colorectal Dis 21: 114-120.
19. Moos V, Schmidt C, Geelhaar A et al (2010) Impaired immune functions of monocytes and macrophages in Whipple's disease. Gastroenterology 138: 210-220.
20. Ghigo E, Barry AO, Pretat L et al (2010) IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation. PLoS One 5: e13561.
21. Marth T, Kleen N, Stallmach A et al (2002) Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease. Gastroenterology 123: 1468-1477.
22. Lagier JC, Lepidi H, Raoult D et al (2010) Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore) 89: 337-345.
23. Mahnel R, Kalt A, Ring S et al (2005) Immunosuppressive therapy in Whipple's disease patients is associated with the appearance of gastrointestinal manifestations. Am J Gastroenterol 100: 1167-1173.
24. Trotta L, Biagi F, Di Stefano M et al (2012) Relationship between previous treatments and onset of symptoms in patients with Whipple's disease. Intern Emerg Med. doi: 10. 1007/s11739-012-0799-4.
25. Di Stefano M, Jorizzo RA, Brusco G et al (1998) Bone mass and metabolism in Whipple's disease: the role of hypogonadism. Scand J Gastroenterol 33: 1180-1185.
26. von Herbay A, Ditton HJ, Maiwald M (1996) Diagnostic application of a polymerase chain reaction assay for the Whipple's disease bacterium to intestinal biopsies. Gastroenterology 110: 1735-1743.
27. Fenollar F, Laouira S, Lepidi H et al (2008) Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of Whipple disease: usefulness of saliva and stool specimens for first-line screening. Clin Infect Dis 47: 659-667.
28. Geissdörfer W, Moos V, Moter A et al (2012) High frequency of Tropheryma whipplei in culture-negative endocarditis. J Clin Microbiol 50: 216-222.
29. Fenollar F, Lepidi H, Raoult D (2001) Whipple's endocarditis: review of the literature and comparisons with Q fever, Bartonella infection, and blood culture-positive endocarditis. Clin Infect Dis 33: 1309-1316.
30. Tak T, Shukla SK (2004) Molecular diagnosis of infective endocarditis: a helpful addition to the Duke criteria. Clin Med Res 2: 206-208.
31. Panegyres PK, Edis R, Beaman M et al (2006) Primary Whipple's disease of the brain: characterization of the clinical syndrome and molecular diagnosis. QJM 99: 609-623.
32. Paulley JW (1952) A case of Whipple's disease (intestinal lipodystrophy). Gastroenterology 22: 128-133.
33. Keinath RD, Merrell DE, Vlietstra R et al (1985) Antibiotic treatment and relapse in Whipple's disease. Long-term follow-up of 88 patients. Gastroenterology 88: 1867-1873.
34. Feurle GE, Junga NS, Marth T (2010) Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology 138: 478-486.
35. Fenollar F, Raoult D (2010) Infection: how should classic Whipple disease be managed? Nat Rev Gastroenterol Hepatol 7: 246-248.
36. Lagier JC, Fenollar F, Lepidi H et al (2010) Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease. J Antimicrob Chemother 65: 2005-2012.
37. Lagier JC, Fenollar F, Lepidi H et al (2011) Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple's disease. J Antimicrob Chemother 66: 1188-1189.
38. von Herbay A, Maiwald M, Ditton HJ et al (1996) Histology of intestinal Whipple's disease revisited. A study of 48 patients. Virchows Arch 429: 335-343.
39. Feurle GE, Moos V, Schinnerling K et al (2010) The immune reconstitution inflammatory syndrome in Whipple disease. A cohort study. Ann Intern Med 153: 710-717.
40. Biagi F, Trotta L, Di Stefano M et al Previous immunosuppressive therapy is a risk factor for immune reconstitution inflammatory syndrome in Whipple's disease. Dig Liver Dis (in press, 2012).